搜索临床试验以:卡培他滨联合顺铂和伊立替康
总计2340个结果
-
Norwegian Breast Cancer Group完全的
-
Qingdao Zhixin Health Technology Co., Ltd.The Affiliated Hospital of Qingdao University未知
-
Hospital Sant Joan de DeuFundació Sant Joan de Déu; Spanish National Health System完全的
-
Jiangsu HengRui Medicine Co., Ltd.招聘中先前接受过曲妥珠单抗和紫杉烷治疗的 HER2 阳性、不可切除和/或转移性乳腺癌受试者中国
-
Johannes Gutenberg University Mainz完全的
-
Heidelberg Pharma AGUnited States Department of Defense完全的
-
Cyteir Therapeutics, Inc.主动,不招人软组织肉瘤 | 滤泡性淋巴瘤 | 乳腺癌 | 头颈癌 | 小细胞肺癌 | 多发性骨髓瘤 | 胰腺癌 | 卵巢癌 | 套细胞淋巴瘤 | 头颈部鳞状细胞癌 | 三阴性乳腺癌 | DLBCL | 非霍奇金淋巴瘤 | 恶性肿瘤 | 慢性淋巴细胞白血病美国
-
Pfizer终止
-
Fudan UniversityHarbin Medical University; Liaoning Tumor Hospital & Institute未知
-
National University Hospital, SingaporeNational Cancer Centre, Singapore未知
-
First Affiliated Hospital of Zhejiang University未知
-
Zhao ChongCancer Institute and Hospital, Chinese Academy of Medical Sciences; Jiangxi Provincial Cancer... 和其他合作者完全的
-
Hunan Province Tumor Hospital尚未招聘
-
Hunan Province Tumor Hospital尚未招聘
-
Second Affiliated Hospital of Nanchang University招聘中
-
Sun Yat-sen University完全的
-
West China HospitalSichuan Provincial People's Hospital; The First People's Hospital of Ziyang; Chengdu City No.2... 和其他合作者尚未招聘
-
Arvinas Androgen Receptor, Inc.主动,不招人
-
BioNumerik Pharmaceuticals, Inc.Lantern Pharma Inc. became Sponsor of Tavocept (BNP7787) IND 051014 as of March 26, 2019.完全的
-
Dutch Colorectal Cancer GroupSanofi; Hoffmann-La Roche; Koningin Wilhelmina Fonds完全的晚期结直肠癌
-
Ivoclar Vivadent AG招聘中
-
Atrial Fibrillation NetworkDaiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company; Preventicus GmbH; Corsano/ MMT; Getemed Medizin-...完全的
-
CStone PharmaceuticalsBlueprint Medicines Corporation完全的